Mezzion Pharma Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-34,929	-19,477	-12,728	-36,298	-13,603
Depreciation & Amortization	988.12	957.8	1,546	1,658	1,586
Loss (Gain) From Sale of Assets	-44.05	471.69	-7.36	-8.99	1.08
Asset Writedown & Restructuring Costs	-	-	-	14,694	-
Stock-Based Compensation	2,140	1,193	421.61	1,293	2,535
Provision & Write-off of Bad Debts	-4.93	162.76	87.18	-20.93	-124.47
Other Operating Activities	18,521	5,282	-1,128	677.64	-4,327
Change in Accounts Receivable	-239.21	1,229	245.93	-150.7	308.73
Change in Inventory	-16.78	209.7	2,643	-313.17	-4,786
Change in Accounts Payable	177.64	-2,456	-3,152	1,474	1,780
Change in Other Net Operating Assets	-3,181	-6,063	1,048	4,921	1,558
Operating Cash Flow	-16,588	-18,489	-11,023	-12,075	-15,071
Capital Expenditures	-137.39	-590.49	-529.29	-767.56	-357.81
Sale of Property, Plant & Equipment	270.3	-	77.72	9.2	-
Cash Acquisitions	-	-	1,192	-	-
Sale (Purchase) of Intangibles	-13,135	-12,888	-11,329	-993.47	-5,825
Investment in Securities	15,000	3,000	-14,967	19,157	-10,151
Other Investing Activities	-1.43	-0	0	5.11	-0
Investing Cash Flow	1,886	-9,576	-25,555	17,410	-16,334
Short-Term Debt Issued	-	880.09	3,226	4,832	3,744
Long-Term Debt Issued	23,000	-	-	-	-
Total Debt Issued	23,000	880.09	3,226	4,832	3,744
Short-Term Debt Repaid	-	-1,380	-3,776	-4,603	-3,786
Long-Term Debt Repaid	-625.93	-556.43	-888.69	-1,157	-1,071
Total Debt Repaid	-625.93	-1,936	-4,665	-5,760	-4,857
Net Debt Issued (Repaid)	22,374	-1,056	-1,439	-927.79	-1,114
Issuance of Common Stock	4,357	1,726	48,653	312	225.77
Other Financing Activities	-	0	-0	-	20,000
Financing Cash Flow	26,731	670.32	47,214	-615.79	19,112
Foreign Exchange Rate Adjustments	-71.98	766.18	211.86	470.01	648.86
Net Cash Flow	11,957	-26,629	10,847	5,189	-11,644
Free Cash Flow	-16,725	-19,080	-11,553	-12,842	-15,429
Free Cash Flow Margin	-211.46%	-221.56%	-36.42%	-41.80%	-57.89%
Free Cash Flow Per Share	-555.46	-639.69	-409.10	-480.39	-578.14
Cash Interest Paid	317.82	293.66	220.24	26.77	7.99
Cash Income Tax Paid	350.86	707.61	209.5	397.25	1,531
Levered Free Cash Flow	12,379	-21,362	-18,701	-3,264	-17,413
Unlevered Free Cash Flow	13,361	-21,174	-18,504	-2,999	-17,211
Change in Working Capital	-3,259	-7,080	785.58	5,930	-1,139

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.